bu 224 and Glioma

bu 224 has been researched along with Glioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, H; Ding, T; Yan, M; Yu, L; Zhang, F; Zhong, Y	1

Other Studies

1 other study(ies) available for bu 224 and Glioma

Article	Year
Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells. The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:1 Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Cell Survival; Dexmedetomidine; Glioma; Glucose; Hypoxia-Inducible Factor 1, alpha Subunit; Idazoxan; Imidazoles; Imidazoline Receptors; Oxygen; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Repressor Proteins; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2012

Article

Year

Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells.

The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:1

Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Cell Survival; Dexmedetomidine; Glioma; Glucose; Hypoxia-Inducible Factor 1, alpha Subunit; Idazoxan; Imidazoles; Imidazoline Receptors; Oxygen; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Repressor Proteins; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2012